NASDAQ:MPLT

Maplight Therapeutics Stock Forecast

etoro logo Buy MPLT
*Your capital is at risk
$12.18
+0.0100 (+0.0822%)
At Close: Aug 10, 2026

Should you buy MPLT stock?

Last updated:

Based on market data through , StockInvest.us rates Maplight Therapeutics, Inc. (MPLT) as a Strong Sell Candidate with a technical score of -7.04 on its -10 to +10 scale. This is a downgrade from Sell in the previous daily evaluation.

  • Sell signal since
  • Price since signal Up 22.97%
  • 3-month trend forecast Down 20.38%
  • Strong Sell Candidate -7.04
AI Analysis AI Analysis of MPLT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add MPLT to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Big movements in Maplight Therapeutics, Inc. stock price on Monday moving 15.31% between high and low
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 27, 2026 Gain 22.97%

The Maplight Therapeutics, Inc. stock price gained 0.0822% on the last trading day (Monday, 10th Aug 2026), rising from $12.17 to $12.18. During the last trading day the stock fluctuated 15.31% from a day low at $10.84 to a day high of $12.50. The price has been going up and down for this period, and there has been a 22.97% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 115 thousand more shares were traded than the day before. In total, 547 thousand shares were bought and sold for approximately $6.67 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $8.48 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -20.38% during the next 3 months and, with a 90% probability hold a price between $6.75 and $27.49 at the end of this 3-month period.

MPLT Signals & Forecast

Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Maplight Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $12.72 and $28.43. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 29, 2026, and so far it has fallen -18.91%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Maplight Therapeutics, Inc. stock

Maplight Therapeutics, Inc. finds support from accumulated volume at $12.17 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.66 between high and low, or 15.31%. For the last week, the stock has had daily average volatility of 9.25%.

Maplight Therapeutics, Inc. is oversold on RSI14 (18). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MPLT) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Maplight Therapeutics, Inc. to open at $11.84, and during the day (based on 14 day Average True Range), to move between $10.73 and $13.63, which gives a possible trading interval of +/-$2.90 (+/-27.00%) up or down from last closing price. If Maplight Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 27.00% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $12.17 (0.08%) than the resistance at $12.31 (1.07%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Maplight Therapeutics, Inc. will release earnings BMO on Thursday, August 13, 2026.The consensus among the analysts for the expected earnings (EPS) is -$1.00. We will update the financials statements for Maplight Therapeutics, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 13.17% in the first trading day after earnings release.

Is Maplight Therapeutics, Inc. stock A Buy?

Maplight Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -7.041 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $11.84 ( 2.79%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

MPLT Performance

Trading levels for MPLT

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 13.50 10.84%
R2 12.87 5.63%
R1 12.47 2.41%
Price 12.18
S1 11.21 -8.00%
S2 10.81 -11.21%
S3 10.18 -16.42%

Accumulated Volume Support & Resistance Levels

Level Price
R3 15.02 23.32%
R2 14.03 15.19%
R1 12.31 1.07%
Price 12.18
S1 12.17 -0.0821%
S2 9.91 -18.68%
S3 0 -

FAQ

What is the symbol for Maplight Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Maplight Therapeutics, Inc. is MPLT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Maplight Therapeutics, Inc. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Maplight Therapeutics, Inc. (MPLT) as a Strong Sell Candidate with a technical score of -7.04 on its -10 to +10 scale. This is a downgrade from Sell in the previous daily evaluation. Since the Sell signal began on Jul 27, 2026, the price has risen 22.97%. The current 3-month trend forecast projects a fall of 20.38%.

How to buy Maplight Therapeutics, Inc. Stock?
Maplight Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Maplight Therapeutics, Inc. Stock.

What's the current price of Maplight Therapeutics, Inc. Stock?
As of the end of day on the Aug 10, 2026, the price of an Maplight Therapeutics, Inc. (MPLT) share was $12.18.

What is the 52-week high and low for Maplight Therapeutics, Inc. Stock?
The 52-week high for Maplight Therapeutics, Inc. Stock is $40.43 and the 52-week low is $9.10.

What is the market capitalization of Maplight Therapeutics, Inc. Stock?
As of the Aug 10, 2026, the market capitalization of Maplight Therapeutics, Inc. is 516.874M.

When is the next earnings date for Maplight Therapeutics, Inc.?
The upcoming earnings date for Maplight Therapeutics, Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE